Familial Pancreatic Cancer PROPHilation Program in Italy

Sex: All

Ages: 18 Years – 80 Years

Phase: NA

Enrollment: 3000

Sponsor: Associazione Italiana per lo Studio del Pancreas

Summary

The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only.Participants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test.Up to 3,000 participants will be enrolled in this study.

Eligibility Criteria

Inclusion Criteria:Being enrolled on the IRFARPC registryHaving familiarity for pancreatic cancer (according to the IRFARPC criteria, Capurso et al. Dig Liv Dis, 2020)Willingness to participate in saliva-swab-based genetic testingExclusion Criteria:- Already known genetic mutation

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05724992). StuddyBuddy aggregates publicly available trial information.